In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels

2013 ◽  
Vol 458 (2) ◽  
pp. 305-314 ◽  
Author(s):  
Wen He ◽  
Xianxi Guo ◽  
Min Feng ◽  
Nina Mao
Keyword(s):  
2012 ◽  
Vol 33 (5) ◽  
pp. 246-256 ◽  
Author(s):  
Bilal S. Abuasal ◽  
Hisham Qosa ◽  
Paul W. Sylvester ◽  
Amal Kaddoumi

Polymers ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1138
Author(s):  
Lixuan Wang ◽  
Shiyan Dong ◽  
Yutong Liu ◽  
Yifan Ma ◽  
Jingjing Zhang ◽  
...  

Injectable hydrogels have been widely applied in the field of regenerative medicine. However, current techniques for injectable hydrogels are facing a challenge when trying to generate a biomimetic, porous architecture that is well-acknowledged to facilitate cell behaviors. In this study, an injectable, interconnected, porous hyaluronic acid (HA) hydrogel based on an in-situ bubble self-generation and entrapment process was developed. Through an amide reaction between HA and cystamine dihydrochloride activated by EDC/NHS, CO2 bubbles were generated and were subsequently entrapped inside the substrate due to a rapid gelation-induced retention effect. HA hydrogels with different molecular weights and concentrations were prepared and the effects of the hydrogel precursor solution’s concentration and viscosity on the properties of hydrogels were investigated. The results showed that HA10-10 (10 wt.%, MW 100,000 Da) and HA20-2.5 (2.5 wt.%, MW 200,000 Da) exhibited desirable gelation and obvious porous structure. Moreover, HA10-10 represented a high elastic modulus (32 kPa). According to the further in vitro and in vivo studies, all the hydrogels prepared in this study show favorable biocompatibility for desirable cell behaviors and mild host response. Overall, such an in-situ hydrogel with a self-forming bubble and entrapment strategy is believed to provide a robust and versatile platform to engineer injectable hydrogels for a variety of applications in tissue engineering, regenerative medicine, and personalized therapeutics.


2019 ◽  
Vol 28 (5) ◽  
pp. 596-606 ◽  
Author(s):  
Jeayoung Park ◽  
Petr Baranov ◽  
Aybike Aydin ◽  
Hany Abdelgawad ◽  
Deepti Singh ◽  
...  

One of the current limitations of retinal transplantation of stem cells as well as other cell types is the dispersion of cells from the injection site (including loss of cells into the vitreous chamber) and low survival after transplantation. Gelatin-hydroxyphenyl propionic acid (Gtn-HPA) conjugate is a biodegradable polymer that can undergo covalent cross-linking in situ, allowing for injection of incorporated cells through a small caliber needle followed by gel formation in vivo. We tested the hypothesis that Gtn-HPA hydrogel supports survival and integration of retinal progenitor cells (RPCs) post-transplantation. In vitro compatibility and in vivo graft survival were assessed by mixing an equal volume of Gtn-HPA conjugate and RPC suspension and triggering enzyme-mediated gelation, using minute amounts of horseradish peroxidase and peroxide. Immunocytochemistry showed >80% survival of cells and minimal apoptosis for cells incorporated into Gtn-HPA, equivalent to controls grown on fibronectin-coated flasks. RPCs undergoing mitosis were seen within the three-dimensional Gtn-HPA hydrogel, but the percentage of Ki-67-positive cells was lower compared with the monolayer controls. For in vivo studies, gel–cell mixture or cell suspension in saline was trans-sclerally injected into the left eye of female Long Evans rats immunosuppressed with cyclosporine A. Grafts survived at the 1 week time point of the study, with Gtn-HPA-delivered grafts showing less inflammatory response demonstrated by anti-leukocyte staining. More eyes in the gel–cell mixture group showed surviving cells in the subretinal space compared with saline-delivered controls, while the number of cells surviving per graft was not significantly different between the two groups. This work demonstrates an injectable in situ cross-linking hydrogel as a potential vehicle for stem cell delivery in the retina.


2016 ◽  
Vol 10 (2) ◽  
pp. 172-186
Author(s):  
Agus Sudibyo ◽  
Tiurlan F. Hutajulu

Morinda Citrifolia, L.  known as Noni or Mengkudu is planting belonging to the family of Rubiaceae. A number of major components have been identified in leaves, roots, fruits of Noni plant, such as scopoletin, octanoic acid, vitamin C, iridoid, terpenoids, alkaloids, anthraquinones, beta-sitosterol, carotene, vitamin A, flavone glycosides, alizarin, amino acids, acubin, austin, caproic acid, caprylic acid and putative procyonine. Its use as a botanical dietary supplement has grown tremendously in recent years. The results of epidemiological studies suggest that the Noni consumption may help prevent several chronic diseases, including cancer disease, cardiovascular disease, type 2 diabetes mellitus, heart disease, artherosclerosis, blood vessel problem, gastric ulcer, drug addiction, muscle ached and pein. Several studies have also demonstrated anti-inflammatory, antioxidant, antimicrobial, analgesic, and immunologicalactivity. Based on a toxicological assessment, Noni juice was considered as safe. Although, a large number of in vitro and to a certain extent, and in vivo studies demonstrated a range potentially beneficial effects, clinical information data are still lacking completely. Therefore, to what extent the information findings from experimental pharmacological studies is not complete at present, so this article reviews potential health benefits for consumptions, its biological effects and looking for a new informationthat needs to be explored in detail before a recommendation can be madeABSTRAKMorinda citrofolia, L (mengkudu) merupakan jenis tanaman yang termasuk dalam golongan Rubiaceadan buahnya dikenal dengan nama Noni atau mengkudu. Beberapa komponen utama dalam tanaman tersebut telah diidentifikasi, mulai dari bagian akar, daun, dan buah, seperti kandungan scopoletin, asam oktanoad, vitamin C, iridoid, terpenoid, alkaloid, anthraquinon, beta-sitosterol, karotene, vitamin A, flavon glikosida, alizarin, asam amino, acubin, austin, asam kaproat, asam kaprilat dan putativ prokseronin. Buah tersebut akhir-akhir ini telah sukses banyak dimanfaatkan sebagai diet suplemen. Hasil studi secara epidemiologi menyatakan bahwa konsumsi mengkudu dapat membantu mencegah beberapa penyakit kronis, seperti penyakit kanker, kardiovaskular, diabetes tipe 2, penyakit jantung, artherosklerosis, masalah pembuluh darah, pencernaan, dan sakit otot. Beberapa studi juga menunjukkan bahwa mengkudu dapat berfungsi sebagai anti inflamasi, antioksidan, antimikroba, analgesik, dan bersifat immunlogis.Berdasarkan kajian secara toksikologi, buah dan jus mengkudu dinyatakan aman untuk dikonsumsi.  Penelitian secara in vitro pada beberapa jenis penyakit tertentu sedang diperluas, dan penelitian secara in vivo menunjukkan bahwa mengkudu mempunyai rentang potensi pengaruh yang baik bagi kesehatan, meskipun data informasinya secara klinis kurang lengkap. Oleh karena itu, untuk mengetahui apa yang sudah ditemukan dari hasil penelitian secara farmalogis yang belum lengkapsaat ini, maka dalam tulisan ini membahas potensi keuntungan kesehatan bila dikonsumsi, pengaruh biologinya dan pencarian informasibaru yang  perlu dikaji lebih rinci sebelum rekomendasi ditetapkan.Kata kunci: Mengkudu (Morinda citrifolia, L), pangan fungsional, rempah medis. 


Author(s):  
Sindhoor S M ◽  
Sneh Priya ◽  
Amala Maxwell

Objective: The aim of the present study was to formulate and evaluate the novel in situ gel of lafutidine for gastroretentive drug deliveryMethods: A gastroretentive in situ gel of lafutidine was formulated by pH-triggered ionic gelation method using different concentrations of gelling polymer such as sodium alginate, gellan gum, and xanthum gum. Prepared formulations were evaluated for viscosity, density, buoyancy lag time and buoyancy duration, and drug content. In vitro drug release studies of all formulations were also performed. In vivo fluorescence imaging study was conducted for optimized formulation and compared with control.Results: The concentration of gelling agents and release retardant polymers significantly affected viscosity, floating behavior, and in vitro drug release of the formulations. The pH and drug content were found in the range of 6.72–7.20 and 88.74–95.33%, respectively. Floating lag time was <2 min; duration of floating was more than 12 h. Minimum and maximum in vitro drug release were found to be for formulation F9 (51.74%) and F1 (82.76%), respectively, at the end of 12 h. The drug was released from the all the formulations in a sustained manner. In vivo studies confirmed the gastroretention of the formulation in mice stomach for 8 h. Stability studies indicated that the there was no significant change in the visual appearance, floating behavior, and drug content.Conclusion: The gastroretentive in situ gel system, prolonged the gastric residence time, thereby targeting site-specific drug release in the upper gastrointestinal tract.


1993 ◽  
Vol 331 ◽  
Author(s):  
S. K. Hobbs ◽  
L. M. Periolat ◽  
L. G. Cima ◽  
M. Nugent ◽  
M. Leunig ◽  
...  

AbstractThere is a need for an in situ assay to quantify tissue reactivity to sustained release of bFGF to better understand and control growth factor-induced angiogenesis. To this end we have adapted the alginate/heparin-sepharose release system for use in the mouse dorsal skinfold chamber. A mathematical model was used to predict the time dependence of bFGF release as a function of bFGF loading, heparin concentration, and device geometry. The model predictions agreed well with previously reported in vitro data. In vivo studies to correlate blood vessel growth as a function of release rate are in progress.


Molecules ◽  
2012 ◽  
Vol 17 (6) ◽  
pp. 6997-7009 ◽  
Author(s):  
Subramanion L. Jothy ◽  
Zuraini Zakariah ◽  
Yeng Chen ◽  
Sreenivasan Sasidharan

Endocrinology ◽  
2012 ◽  
Vol 153 (11) ◽  
pp. 5575-5586 ◽  
Author(s):  
Julie M. Sroga ◽  
Fei Gao ◽  
Xinghong Ma ◽  
Sanjoy K. Das

Abstract Uterine decidualization, a crucial process for implantation, is a tightly regulated process encompassing proliferation, differentiation, and polyploidization of uterine stromal cells. Hoxa (Homeobox A)-10, a homeobox transcription factor, is highly expressed in decidualizing stromal cells. Targeted gene deletion experiments have demonstrated marked infertility resulting from severely compromised decidualization in Hoxa-10−/− mice. However, the underlying mechanism by which Hoxa-10 regulates stromal cell differentiation remains poorly understood. Cyclin D3, a G1 phase cell-cycle regulatory protein involved in stromal cell proliferation and decidualization, is significantly reduced in Hoxa-10−/− mice. The expression of cyclin D3 in the pregnant mouse uterus parallels stromal cell decidualization. Here, we show that adenovirus-driven cyclin D3 replacement in Hoxa-10−/− mice improves stromal cell decidualization. To address our question of whether cyclin D3 replacement in Hoxa-10−/− mice can improve decidualization, both in vitro and in vivo studies were completed after the addition of cyclin D3 or empty (control) viral vectors. Immunostaining demonstrated increased proliferation and decidualization in both in vitro and in vivo studies, and in situ hybridization confirmed increased expression of decidualization markers in vivo. Placentation was demonstrated as well in vivo in the cyclin D3-replaced animals. However, fertility was not restored in Hoxa-10−/− mice after d 10 of pregnancy. Finally, we identified several downstream targets of cyclin D3 during decidualization in vitro via proteomics experiments, and these were confirmed using in situ hybridization in vivo. Collectively, these results demonstrate that cyclin D3 expression influences a host of genes involved in decidualization and can improve decidualization in Hoxa-10−/− mice.


Sign in / Sign up

Export Citation Format

Share Document